ELAN
Price
$24.54
Change
+$0.35 (+1.45%)
Updated
Jan 16, 04:59 PM (EDT)
Capitalization
12.01B
40 days until earnings call
Intraday BUY SELL Signals
SBFM
Price
$1.22
Change
-$0.00 (-0.00%)
Updated
Jan 16, 04:59 PM (EDT)
Capitalization
5.99M
40 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ELAN vs SBFM

Header iconELAN vs SBFM Comparison
Open Charts ELAN vs SBFMBanner chart's image
Elanco Animal Health
Price$24.54
Change+$0.35 (+1.45%)
Volume$86.52K
Capitalization12.01B
Sunshine Biopharma
Price$1.22
Change-$0.00 (-0.00%)
Volume$407
Capitalization5.99M
ELAN vs SBFM Comparison Chart in %
ELAN
Daily Signal:
Gain/Loss:
SBFM
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ELAN vs. SBFM commentary
Jan 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Hold and SBFM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 17, 2026
Stock price -- (ELAN: $24.18 vs. SBFM: $1.22)
Brand notoriety: ELAN: Notable vs. SBFM: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ELAN: 95% vs. SBFM: 81%
Market capitalization -- ELAN: $12.01B vs. SBFM: $5.99M
ELAN [@Pharmaceuticals: Generic] is valued at $12.01B. SBFM’s [@Pharmaceuticals: Generic] market capitalization is $5.99M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 1 FA rating(s) are green whileSBFM’s FA Score has 0 green FA rating(s).

  • ELAN’s FA Score: 1 green, 4 red.
  • SBFM’s FA Score: 0 green, 5 red.
According to our system of comparison, ELAN is a better buy in the long-term than SBFM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 6 TA indicator(s) are bullish while SBFM’s TA Score has 4 bullish TA indicator(s).

  • ELAN’s TA Score: 6 bullish, 4 bearish.
  • SBFM’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ELAN is a better buy in the short-term than SBFM.

Price Growth

ELAN (@Pharmaceuticals: Generic) experienced а +4.04% price change this week, while SBFM (@Pharmaceuticals: Generic) price change was -10.95% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.93%. For the same industry, the average monthly price growth was +6.56%, and the average quarterly price growth was +18.67%.

Reported Earning Dates

ELAN is expected to report earnings on Feb 25, 2026.

SBFM is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.93% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($12B) has a higher market cap than SBFM($5.99M). ELAN has higher P/E ratio than SBFM: ELAN (345.43) vs SBFM (0.23). ELAN YTD gains are higher at: 6.849 vs. SBFM (-0.813). ELAN has higher annual earnings (EBITDA): 840M vs. SBFM (-6.2M). ELAN has more cash in the bank: 505M vs. SBFM (9.31M). SBFM has less debt than ELAN: SBFM (855K) vs ELAN (4.02B). ELAN has higher revenues than SBFM: ELAN (4.59B) vs SBFM (37.3M).
ELANSBFMELAN / SBFM
Capitalization12B5.99M200,501%
EBITDA840M-6.2M-13,547%
Gain YTD6.849-0.813-842%
P/E Ratio345.430.23150,346%
Revenue4.59B37.3M12,308%
Total Cash505M9.31M5,427%
Total Debt4.02B855K470,643%
FUNDAMENTALS RATINGS
ELAN vs SBFM: Fundamental Ratings
ELAN
SBFM
OUTLOOK RATING
1..100
2664
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9096
PRICE GROWTH RATING
1..100
3888
P/E GROWTH RATING
1..100
275
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBFM's Valuation (43) in the null industry is somewhat better than the same rating for ELAN (94) in the Agricultural Commodities Or Milling industry. This means that SBFM’s stock grew somewhat faster than ELAN’s over the last 12 months.

SBFM's Profit vs Risk Rating (100) in the null industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that SBFM’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's SMR Rating (90) in the Agricultural Commodities Or Milling industry is in the same range as SBFM (96) in the null industry. This means that ELAN’s stock grew similarly to SBFM’s over the last 12 months.

ELAN's Price Growth Rating (38) in the Agricultural Commodities Or Milling industry is somewhat better than the same rating for SBFM (88) in the null industry. This means that ELAN’s stock grew somewhat faster than SBFM’s over the last 12 months.

ELAN's P/E Growth Rating (2) in the Agricultural Commodities Or Milling industry is significantly better than the same rating for SBFM (75) in the null industry. This means that ELAN’s stock grew significantly faster than SBFM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANSBFM
RSI
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 10 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ELAN
Daily Signal:
Gain/Loss:
SBFM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
THC201.326.13
+3.14%
Tenet Healthcare Corp
FGMC10.10N/A
N/A
FG Merger II Corp
INSW55.78-0.68
-1.20%
International Seaways
KROS19.26-0.27
-1.38%
Keros Therapeutics
FCUV0.70-0.05
-7.05%
Focus Universal

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with VTRS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
-1.06%
VTRS - ELAN
48%
Loosely correlated
-2.36%
ZTS - ELAN
48%
Loosely correlated
-0.45%
PAHC - ELAN
41%
Loosely correlated
+0.48%
SNDL - ELAN
39%
Loosely correlated
-0.61%
AMPH - ELAN
37%
Loosely correlated
-6.34%
More

SBFM and

Correlation & Price change

A.I.dvisor tells us that SBFM and NBIX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBFM and NBIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBFM
1D Price
Change %
SBFM100%
-0.81%
NBIX - SBFM
28%
Poorly correlated
-1.46%
VTRS - SBFM
26%
Poorly correlated
-2.36%
HROW - SBFM
26%
Poorly correlated
+0.69%
OGI - SBFM
26%
Poorly correlated
-1.24%
ELAN - SBFM
26%
Poorly correlated
-1.06%
More